Karen Flynn Net Worth & Insider Trades
Karen Flynn - Director, Recro Pharma, Inc
What is Karen Flynn's Net Worth?
The current estimated net worth of Recro Pharma, Inc's Director, Karen Flynn, is estimated to be about $14.1M . Karen Flynn owns about 800 units of Recro Pharma, Inc common stock. In the last 4 years at Recro Pharma, Inc, Karen Flynn has sold an estimated value of $0 worth.
What is Karen Flynn's Past Insider Trading?
Karen Flynn's largest purchase order was 800 units , worth over $5.36K on December 19, 2016. In total, Karen Flynn has made about 8 transactions over 4 years of their time at Recro Pharma, Inc. Karen Flynn usually trades in May, with the busiest year in 2019, 2015 and 2018.
Karen Flynn
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Karen Flynn's' Mailing Address?
- Mailing address is C/o Catalent, Inc. 14 Schoolhouse Road Somerset NJ 08873 NJ
Recro Pharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| J. David Enloe, Jr. | 2020 | $10,577 | - | $660,001 | $400,544 | - | $1,678 | $1,072,800 |
| Ryan D. Lake | 2020 | $198,985 | $48,000 | $1,058,040 | $744,327 | $107,640 | $24,673 | $2,181,665 |
| Ryan D. Lake | 2019 | $319,777 | $69,440 | $623,276 | $334,200 | $138,880 | $44,038 | $1,529,611 |
| Gerri Henwood | 2020 | $308,654 | $111,240 | - | - | - | $21,166 | $441,060 |
| Gerri Henwood | 2019 | $553,846 | - | $2,608,537 | $1,062,199 | $360,000 | $38,402 | $4,622,984 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1588972/000156459021015283/reph-def14a_20210420.htm
What are Recro Pharma, Inc's Past Insider Trades?
Recro Pharma, Inc's most recent insider trade came on March 17, 2022 by David Enloe Jr who bought 512 units worth $1K . In the last 8 years, insiders at Recro Pharma, Inc have sold an estimated value of $26.27M and bought an estimated value of $15.87M worth of shares. Insider trading is most common in December, with the busiest year in 2017. The most active traders at the company are Ryan D. Lake, Chief Financial Officer, Geraldine Henwood, Director, and Scp Vitalife Partners Ii Lp .
Recro Pharma, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||